4.7 Article

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 132, Issue 3, Pages 575-+

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2013.05.041

Keywords

Childhood asthma; asthma endotypes; wheeze phenotypes; longitudinal analysis

Funding

  1. JP Moulton Charitable Foundation
  2. MRC [G0601361, MR/K002449/1]
  3. National Institute for Health Research Clinical Research Facility at University Hospital of South Manchester NHS Foundation Trust
  4. Asthma UK [04/014]
  5. Medical Research Council
  6. Asthma UK
  7. GlaxoSmithKline
  8. Research Council Grant from the University of Manchester
  9. National Institute for Health
  10. Moulton Charitable Foundation
  11. Thermo Fisher Scientific
  12. Airsonet
  13. Novartis
  14. Merck Sharp Dohme
  15. ALK-Abello
  16. MRC [MR/K006665/1, G0601361, MR/K002449/1] Funding Source: UKRI
  17. Medical Research Council [MC_PC_13042, MR/K006665/1, MR/K002449/1, G0601361] Funding Source: researchfish

Ask authors/readers for more resources

Background: Previous studies have suggested the presence of different childhood wheeze phenotypes through statistical modeling based on parentally reported wheezing. Objective: We sought to investigate whether joint modeling of observations from both medical records and parental reports helps to more accurately define wheezing disorders during childhood and whether incorporating information from medical records better characterizes severity. Methods: In a population-based birth cohort (n = 1184), we analyzed data from 2 sources (parentally reported current wheeze at 4 follow-ups and physician-confirmed wheeze from medical records in each year from birth to age 8 years) to determine classes of children who differ in wheeze trajectories. We tested the validity of these classes by examining their relationships with objective outcomes (lung function, airway hyperreactivity, and atopy), asthma medication, and severe exacerbations. Results: Longitudinal latent class modeling identified a 5-class model that best described the data. We assigned classes as follows: no wheezing (53.3%), transient early wheeze (13.7%), late-onset wheeze (16.7%), persistent controlled wheeze (13.1%), and persistent troublesome wheeze (PTW; 3.2%). Longitudinal trajectories of atopy and lung function differed significantly between classes. Patients in the PTW class had diminished lung function and more hyperreactive airways compared with all other classes. We observed striking differences in exacerbations, hospitalizations, and unscheduled visits, all of which were markedly higher in patients in the PTW class compared with those in the other classes. For example, the risk of exacerbation was much higher in patients in the PTW class compared with patients with persistent controlled wheeze (odds ratio [OR], 3.58; 95% CI, 1.27-10.09), late-onset wheeze (OR, 15.92; 95% CI, 5.61-45.15), and transient early wheeze (OR, 12.24; 95% CI, 4.28-35.03). Conclusion: We identified a novel group of children with persistent troublesome wheezing, who have markedly different outcomes compared with persistent wheezers with controlled disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available